These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 17508213

  • 1. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.
    Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
    [Abstract] [Full Text] [Related]

  • 2. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S, Cerutti R, Placidi C, Marchet S, Carnevali I, Bernasconi B, Proserpio I, Pinotti G, Tibiletti MG, Furlan D, Capella C.
    J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.
    Life Sci; 2010 Jul 17; 87(3-4):83-91. PubMed ID: 20470789
    [Abstract] [Full Text] [Related]

  • 4. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.
    Hum Pathol; 2009 Nov 17; 40(11):1534-42. PubMed ID: 19695681
    [Abstract] [Full Text] [Related]

  • 5. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
    Hoffmann AC, Kaifi JT, Vallböhmer D, Yekebas E, Grimminger P, Leers JM, Izbicki JR, Hölscher AH, Schneider PM, Metzger R, Brabender J.
    J Surg Oncol; 2009 Oct 01; 100(5):414-7. PubMed ID: 19653236
    [Abstract] [Full Text] [Related]

  • 6. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
    Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H.
    Int J Oncol; 2008 Sep 01; 33(3):469-75. PubMed ID: 18695875
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK, Ibrahim M, Al-Rasheed M, Bu R, Bavi P, Jehan Z, Abubaker J, Murad W, Al-Dayel F, Ezzat A, El-Solh H, Uddin S, Al-Kuraya K.
    Ann Hematol; 2007 Dec 01; 86(12):887-95. PubMed ID: 17712558
    [Abstract] [Full Text] [Related]

  • 8. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 01; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 9. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
    Yuregir OO, Yurtcu E, Kizilkilic E, Kocer NE, Ozdogu H, Sahin FI.
    Int J Lab Hematol; 2010 Apr 01; 32(2):142-9. PubMed ID: 19302404
    [Abstract] [Full Text] [Related]

  • 10. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H, Geeraerts H, Verbeken E, Nuyts S.
    Oncol Rep; 2009 Feb 01; 21(2):507-13. PubMed ID: 19148529
    [Abstract] [Full Text] [Related]

  • 11. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 01; 13(6):967-75. PubMed ID: 15184253
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
    Al-Kuraya KS, Siraj AK, Al-Dayel FA, Ezzat AA, Al-Jommah NA, Atizado VL, Narayanappa RN.
    Saudi Med J; 2005 Jul 01; 26(7):1099-103. PubMed ID: 16047061
    [Abstract] [Full Text] [Related]

  • 13. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
    Vallböhmer D, Brabender J, Yang D, Schneider PM, Metzger R, Danenberg KD, Hölscher AH, Danenberg PV.
    Clin Lung Cancer; 2006 Jul 01; 8(1):39-44. PubMed ID: 16870044
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
    Brell M, Tortosa A, Verger E, Gil JM, Viñolas N, Villá S, Acebes JJ, Caral L, Pujol T, Ferrer I, Ribalta T, Graus F.
    Clin Cancer Res; 2005 Jul 15; 11(14):5167-74. PubMed ID: 16033832
    [Abstract] [Full Text] [Related]

  • 15. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 16. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
    Sasai K, Nodagashira M, Nishihara H, Aoyanagi E, Wang L, Katoh M, Murata J, Ozaki Y, Ito T, Fujimoto S, Kaneko S, Nagashima K, Tanaka S.
    Am J Surg Pathol; 2008 Aug 01; 32(8):1220-7. PubMed ID: 18580490
    [Abstract] [Full Text] [Related]

  • 17. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR, Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J.
    Cancer Invest; 2009 Oct 01; 27(8):825-9. PubMed ID: 19544111
    [Abstract] [Full Text] [Related]

  • 18. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas.
    Lee SM, Lee EJ, Ko YH, Lee SH, Maeng L, Kim KM.
    APMIS; 2009 Feb 01; 117(2):87-94. PubMed ID: 19239430
    [Abstract] [Full Text] [Related]

  • 20. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.
    Cancer Res; 2001 Jan 01; 61(1):249-55. PubMed ID: 11196170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.